Article Details

Pfizer extends collaboration with disease model co CytoReason - Globes English

Retrieved on: 2022-09-20 12:48:13

Tags for this article:

Click the tags to see associated articles and topics

Pfizer extends collaboration with disease model co CytoReason - Globes English. View article details on hiswai:

Excerpt

Pfizer will invest $20 million, and in total the deal could be worth $110 million to Israeli company CytoReason over five years.

Article found on: en.globes.co.il

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up